AFP and hepatocellular carcinoma: The combined assessment of hsa‐mir‐155‐5p and AFP has demonstrated improved sensitivity in diagnosing HCC, and the ratio of hsa‐mir‐155‐5p to hsa‐mir‐199a‐5p has emerged as a promising molecular marker for patients with AFP‐negative HCC.59